Skip to content
Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Primary Menu Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us
  • Featured

India Adds Over 49,000 New Covid-19 Cases In A Day

Jul 24, 2020 | Pratirodh Bureau

A healthcare worker wearing protective gear takes a swab from a boy amidst the coronavirus disease outbreak, at a residential area in Ahmedabad on July 24, 2020

India reported over 49,000 fresh cases of the novel coronavirus with 740 new deaths on Friday, marking the biggest daily surge in cases even as officials in some states complained of shortages of vital drugs for those hospitalized.

As the number of cases neared 1.3 million in India, local authorities scrambled to procure generic versions of remdesivir, the drug that has shown promise in clinical trials in treating severely-ill patients with COVID-19, the disease caused by the coronavirus.

“Demand is huge as cases are rising rapidly in the state,” said a senior drug regulatory official in the western state of Maharashtra. “Supplies of the drug are limited, but companies have assured us they will provide more in a week.”

India has reported 30,601 deaths from the disease, with more than 40% of these deaths coming from Maharashtra state.

The western state is the worst-affected, having recorded nearly 350,000 cases, of which almost 60% were reported in the country’s financial capital, Mumbai, and its satellite towns.

Remdesivir, made by the U.S. drugmaker Gilead Sciences Inc, has been in high demand globally amid the pandemic, and Gilead in May and June authorized six Indian companies, and three foreign ones, to make and sell generic versions of the drug in 127 developing nations.

Only three of these firms with operations in India – Hetero Labs Ltd, Cipla and Mylan NV have so far been able to start supplying. Others are either awaiting regulatory approvals or still setting up production.

Several hospitals have struggled to get the drug as patient numbers increased in a county whose public health system is one of the world’s most poorly-funded. India has the third-highest number of coronavirus cases after the United States and Brazil.

Drug industry and government officials in the country said that they are doing their best.

“These things cannot be done in a hurry,” said P.D. Vaghela, an official at India’s Department of Pharmaceuticals, adding the drug regulator was working on granting approvals to companies for generic remdesivir at the earliest.

“Some people were engaging in black marketing but we have taken strict action against them,” Vaghela said.

Tags: coronavirus, coronavirus disease, COVID-19, Department of Pharmaceuticals, drug regulator, Maharashtra, Mumbai, Pratirodh, remdesivir

Continue Reading

Previous Comments On My Independence ‘Unacceptable & Untrue’: WHO Chief
Next Scavengers In India Risk Health To Sift Coronavirus Debris

More Stories

  • Featured

“Father’s Death Biggest Learning Experience”

11 hours ago Pratirodh Bureau
  • Featured

No Greater Feminist Than Draupadi And Sita: JNU VC

11 hours ago Pratirodh Bureau
  • Featured

Texas Shooting: Biden Says “We Have To Act”

17 hours ago Pratirodh Bureau

Recent Posts

  • “Father’s Death Biggest Learning Experience”
  • No Greater Feminist Than Draupadi And Sita: JNU VC
  • Texas Shooting: Biden Says “We Have To Act”
  • Twin Crises Of Heat & Floods Expose Neglect
  • Polarisation Affecting India’s Growth: Basu
  • Monkeypox: What Is It & How Can We Prevent Its Spread?
  • Af Women TV Presenters Vow To Fight Order To Cover Faces
  • CAA Protests Against Unjust Law, Not Against Sovereign: Umar Khalid
  • Assam: Opposition Decries Bulldozer ‘Revenge’
  • Ukraine: Russian Soldier Jailed For Life In First War Crimes Trial
  • Time To Tax The Rich: Oxfam At Davos
  • ‘Farmers Can Change Govt, If They Want’
  • War Through The Eyes Of Ukrainian Kids
  • ‘Ample Suspicion’ Yet Court Acquits Two Cops Of Tribal Girl’s Rape, Murder
  • Hindu College Prof Held For Post On ‘Shivling’ At Gyanvapi Mosque
  • North India Caught In Vicious Cycle Of Forest Fires, Heatwaves
  • ‘Pavlovian Response’: India Rejects Remarks By Bilawal Zardari At UN
  • Pegasus Row: SC Grants More Time To Panel To Submit Report
  • Climate Change: Extreme Heat Waves In India 100 Times More Likely
  • The Dark Side Of Social Media Influencing

Search

Main Links

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us

Related Stroy

  • Featured

“Father’s Death Biggest Learning Experience”

11 hours ago Pratirodh Bureau
  • Featured

No Greater Feminist Than Draupadi And Sita: JNU VC

11 hours ago Pratirodh Bureau
  • Featured

Texas Shooting: Biden Says “We Have To Act”

17 hours ago Pratirodh Bureau
  • Featured

Twin Crises Of Heat & Floods Expose Neglect

18 hours ago Pratirodh Bureau
  • Featured

Polarisation Affecting India’s Growth: Basu

1 day ago Pratirodh Bureau

Recent Posts

  • “Father’s Death Biggest Learning Experience”
  • No Greater Feminist Than Draupadi And Sita: JNU VC
  • Texas Shooting: Biden Says “We Have To Act”
  • Twin Crises Of Heat & Floods Expose Neglect
  • Polarisation Affecting India’s Growth: Basu
Copyright © All rights reserved. | CoverNews by AF themes.